- Home
- EIX vs RVMD Comparison
EIX vs RVMD Comparison
Compare EIX & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIX | RVMD |
|---|---|---|
| Founded | 1886 | 2014 |
| Country | United States | United States |
| Employees | 13725 | 883 |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1B | 30.1B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | EIX | RVMD |
|---|---|---|
| Price | $72.63 | $153.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 19 |
| Target Price | $72.09 | ★ $140.84 |
| AVG Volume (30 Days) | 2.3M | ★ 2.5M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.17% | N/A |
| EPS Growth | ★ 248.94 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $19,317,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.17 | $533.02 |
| P/E Ratio | $52.83 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $47.73 | $34.00 |
| 52 Week High | $76.22 | $166.50 |
Technical Indicators
Market Signals| Indicator | EIX | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.45 | 55.40 |
| Support Level | $68.62 | $93.39 |
| Resistance Level | $73.87 | $166.50 |
| Average True Range (ATR) | 1.46 | 6.30 |
| MACD | 0.19 | -1.41 |
| Stochastic Oscillator | 75.30 | 48.60 |
Price Performance
Historical ComparisonAbout EIX Edison International
Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.